Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subconjunctival bupivacaine for pain after squint surgery
NCT04782960Unknown
- Sponsor
- Fayoum University
- Start
- Apr 2021
- Primary completion
- May 2021
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial in postoperative pain comparing Bupivacaine Group with Placebo Group (2 arms). Primary endpoint: Visual Analog Scale at 5 months. Status: unknown.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04782960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04782960.